Linkedin-in Facebook-f
Technologies
Researchers
Portfolio Companies
Lab Capabilities
  • About Us
    • About Us
    • Staff and Board of Directors
  • Industry & Investors
    • Partnership Models
    • Venture Funds
    • Courses
  • Success Stories
  • Media Center
    • News
    • Podcasts
    • Press Releases
  • Faculty & Researchers
  • Contact Us
  • Download Yissum Deck
  • About Us
    • About Us
    • Staff and Board of Directors
  • Industry & Investors
    • Partnership Models
    • Venture Funds
    • Courses
  • Success Stories
  • Media Center
    • News
    • Podcasts
    • Press Releases
  • Faculty & Researchers
  • Contact Us
  • Download Yissum Deck
Briefcase Loading...

Check all that apply

Portfolio Category: Pharmaceuticals

Synovio Therapeutics

A therapeutics company developing novel treatments for chronic inflammatory or degenerative diseases, often focused on synovial tissue, joint diseases (e.g., osteoarthritis), or targeted biologics.
Pharmaceuticals

Synovio Therapeutics

A therapeutics company developing novel treatments for chronic inflammatory or degenerative diseases, often focused on synovial tissue, joint diseases (e.g., osteoarthritis), or targeted biologics.

Established in 2022 by

Prof. Mona Dvir-Ginzberg

BD Contact

Ariela Markel

Summary

Pharmaceuticals

https://synoviotx.com

Linkedin-in

Scopus BioPharma

CBD-mediated activation of nociceptive TRPV1 and TRPV2 channels for painless pain-selective anesthesia technology
Pharmaceuticals

Scopus BioPharma

CBD-mediated activation of nociceptive TRPV1 and TRPV2 channels for painless pain-selective anesthesia technology

Established in 2017 by

Prof. Dmitry Tsvelikhovsky

BD Contact

Ariela Markel

Summary

Pharmaceuticals

https://scopusbiopharma.com

Linkedin-in

RNAble Ltd.

Enhancing mRNA stability as therapy for genetic diseases and cancer FTO inhibition), First probable indication: DMD. Partnership: Integra (under FAO) + FutuRx (establishment of newco – RNAble)
Pharmaceuticals

RNAble Ltd.

Enhancing mRNA stability as therapy for genetic diseases and cancer FTO inhibition), First probable indication: DMD. Partnership: Integra (under FAO) + FutuRx (establishment of newco – RNAble)

Established in 2021 by

Prof. Rotem Karni

BD Contact

Ariela Markel

Summary

Pharmaceuticals
Linkedin-in

RENOVARIS Ltd.

Renovaris, company of NGT Incubator on the Technology of Profs. Benita and Taher on the licensed technology relates to topical compositions and methods for treating alopecia
Pharmaceuticals

RENOVARIS Ltd.

Renovaris, company of NGT Incubator on the Technology of Profs. Benita and Taher on the licensed technology relates to topical compositions and methods for treating alopecia

Established in 2026 by

Prof. Simon Benita

BD Contact

Ariela Markel

Summary

Pharmaceuticals

https://renovarispharma.com

Linkedin-in

Renasis Bio

Regulatory RNA Regions Validation Using Blocking ASOs
Pharmaceuticals

Renasis Bio

Regulatory RNA Regions Validation Using Blocking ASOs

Established in 2025 by

Dr. Raphael Isaac Isaac Benhamou

BD Contact

Ariela Markel

Summary

Pharmaceuticals

https://www.renasis.bio

Linkedin-in

Pulsetech Medical Ltd.

Cutting-edge adaptive DBS technique to modulate disease progression of neurodegenerative diseases
Pharmaceuticals

Pulsetech Medical Ltd.

Cutting-edge adaptive DBS technique to modulate disease progression of neurodegenerative diseases

Established in 2025 by

Prof. Hagai Bergman

BD Contact

Ariela Markel

Summary

Pharmaceuticals
Linkedin-in

Prudentix

Amelogenin for Regeneration of mesenchymal tissues: Ligaments, Tendons, Cartilage, Bone
Pharmaceuticals

Prudentix

Amelogenin for Regeneration of mesenchymal tissues: Ligaments, Tendons, Cartilage, Bone

Established in 2018 by

BD Contact

Ariela Markel

Summary

Pharmaceuticals

https://prudentix.com/

Linkedin-in

Prophex Ltd.

A pharmaceutical or biotech company working on therapeutic formulations, often focusing on proprietary drug-delivery systems, chemical compounds, or targeted therapies.
Pharmaceuticals

Prophex Ltd.

A pharmaceutical or biotech company working on therapeutic formulations, often focusing on proprietary drug-delivery systems, chemical compounds, or targeted therapies.

Established in 2025 by

Prof. Yaakov Nahmias

BD Contact

Ariela Markel

Summary

Pharmaceuticals
Linkedin-in

Altimmune

Development of effective countermeasures to a range of potential biological and chemical weapons
Pharmaceuticals

Altimmune

Development of effective countermeasures to a range of potential biological and chemical weapons

Established in 2001 by

Prof. Hermona Soreq

BD Contact

Ariela Markel

Summary

Pharmaceuticals

https://altimmune.com/

Linkedin-in

Nobio Ltd.

Antimicrobial and/or antibiofilm additives.
Pharmaceuticals

Nobio Ltd.

Antimicrobial and/or antibiofilm additives.

Established in 2015 by

Prof. Abraham Jacob Domb

BD Contact

Ariela Markel

Summary

Pharmaceuticals

https://www.nobio.com

Linkedin-in
ADDRESS

Hi-Tech Park, Edmond J. Safra
Campus, Bungalow 2.6
Givat-Ram, Jerusalem
P.O. Box 39135
91390 Israel

CONTACT US
  • Phone: +972-2-658-6688
  • Email: [email protected]
FOLLOW US
Twitter Linkedin-in Facebook-f Youtube
COPYRIGHT
Twitter Linkedin-in Facebook-f Youtube
  • About Us
    • About Us
    • Staff and Board of Directors
  • Industry & Investors
    • Partnership Models
    • Venture Funds
    • Courses
  • Success Stories
  • Media Center
    • News
    • Podcasts
    • Press Releases
  • Faculty & Researchers
  • Contact Us
  • Download Yissum Deck
Technologies
Researchers
Our Portfolio Companies
Lab Capabilities
Briefcase Loading...